SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-331065
Filing Date
2017-11-02
Accepted
2017-11-02 16:27:07
Documents
7
Period of Report
2017-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d472956d8k.htm 8-K 20548
2 EX-1.1 d472956dex11.htm EX-1.1 116397
3 EX-4.2 d472956dex42.htm EX-4.2 90737
4 EX-5.1 d472956dex51.htm EX-5.1 18649
5 EX-12.1 d472956dex121.htm EX-12.1 24895
6 GRAPHIC g472956001.jpg GRAPHIC 3460
7 GRAPHIC g472956002.jpg GRAPHIC 2324
  Complete submission text file 0001193125-17-331065.txt   280680
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 171172773
SIC: 2836 Biological Products, (No Diagnostic Substances)